Publications about COVID-19 for Laboratories

Publications about COVID-19 for Laboratories
Updated May 20, 2020

Severe acute respiratory syndrome coronavirus 2 from patient with 2019 novel coronavirus disease, United States

Harcourt J, Tamin A, Lu X , et al. Emerg Infect Dis. June 2020. doi:10.3201/eid2606.200516.

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Sheahan T, Sims A, Zhou S, et al. Sci Transl Med. 2020 Apr 29;12(541). pii: eabb5883. doi: 10.1126/scitranslmed.abb5883. Epub 2020 Apr 6. PMID:  32253226

Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility

Arons M, Hatfield K, Reddy S, et al. N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMoa2008457. [Epub ahead of print] PMID:  32329971

Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States

COVID-19 Investigation Team. Nat Med. 2020 Apr 23. doi: 10.1038/s41591-020-0877-5. [Epub ahead of print] PMID: 32327757

Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1

van Doremalen N, Bushmaker T, Morris, D, et al. 382(16), 1564-1567. N Engl J Med. April 16, 2020. doi:10.1056/

Multiple respiratory syncytial virus introductions into a neonatal intensive care unit

Rose E, Washington E, Wang L, et al. J Pediatric Infect Dis Soc. 2020 Apr 4. pii: piaa026. doi: 10.1093/jpids/piaa026. [Epub ahead of print]  PMID: 32249314

Mesoscale reaction-diffusion phenomena governing lignin-first biomass fractionation

Thornburg N, Pecha M, Brandner D, et al. ChemSusChem. 2020 Apr 3. doi: 10.1002/cssc.202000558. [Epub ahead of print] PMID: 32246557

First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) in the USA

Ghinai I, McPherson T, Hunter J, et al. The Lancet. Published online March 12, 2020. doi: https: 10.1016/S0140-6736(20)30607-3